Importantly, this medication is not recommended for individuals with a history of thyroid cancer or Multiple Endocrine Neoplasia
Inactive ingredient ratings Nutrients Acetyl L-Carnitine 500mg How this compares to other Carnitine products Popularity Low Carnitine products Quality rank Average Higher TrustScore than 63% of Carnitine products Loading related products

The patient must: Be age 18 or older Have eligible Medicare Part D coverage Be prescribed treatment specifically for weight reduction and maintenance Participate in ongoing nutrition and physical activity intervention Not have already received a GLP-1 through their Part D plan Not be seeking coverage for another Part D-coverable indication, such as type 2 diabetes, moderate-to-severe obstructive sleep apnea, MASH, or cardiovascular risk reduction The patient must also have met one of these criteria when GLP-1 therapy was originally started: BMI 35 BMI 30 plus HFpEF, uncontrolled hypertension despite 2 medications, or CKD stage 3a+ BMI 27 plus prediabetes, prior MI, prior stroke, or symptomatic peripheral artery disease Important: Eligibility is based on BMI at treatment initiation, not necessarily the patients current BMI
Hashimotos Thyroiditis Considerations Hashimotos thyroiditis, the most common cause of hypothyroidism in the United States, is an autoimmune condition
It is the same linear peptide, specifically developed and studied for its high selectivity for the MC1 receptor and its photoprotective effects
The most important group for weight loss is GLP-1 receptor agonists such as semaglutide and liraglutide